Why are so few antipsychotic drugs licensed for Alzheimer's disease related behavioral and psychological symptoms?. (2nd November 2019)

Record Type:
Journal Article
Title:
Why are so few antipsychotic drugs licensed for Alzheimer's disease related behavioral and psychological symptoms?. (2nd November 2019)
Main Title:
Why are so few antipsychotic drugs licensed for Alzheimer's disease related behavioral and psychological symptoms?
Authors:
Calsolaro, Valeria
Antognoli, Rachele
Monzani, Fabio
Abstract:
Is Part Of:
Expert review of neurotherapeutics. Volume 19:Number 11(2019)
Journal:
Expert review of neurotherapeutics
Issue:
Volume 19:Number 11(2019)
Issue Display:
Volume 19, Issue 11 (2019)
Year:
2019
Volume:
19
Issue:
11
Issue Sort Value:
2019-0019-0011-0000
Page Start:
1051
Page End:
1053
Publication Date:
2019-11-02
Subjects:
Alzheimer's disease -- pharmacological therapy -- nonpharmacological therapy -- behavioral and psychological symptoms -- antipsychotic drugs -- safety
Neuropharmacology -- Periodicals
615.7805
Journal URLs:
http://www.expert-reviews.com/loi/ern ↗
http://www.future-drugs.com/loi/ern ↗
http://www.tandfonline.com/toc/iern20/current ↗
http://informahealthcare.com ↗
DOI:
10.1080/14737175.2019.1641407 ↗
Languages:
English
ISSNs:
1473-7175
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 3842.002995
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store
Ingest File:
11869.xml